EP Patent

EP3228306A1 — Complex compound comprising obeticholic acid and cyclodextrin and pharmaceutical formulation comprising the complex compound

Assigned to Ratiopharm GmbH · Expires 2017-10-11 · 9y expired

What this patent protects

The present invention relates to a complex compound comprising obeticholic acid and cyclodextrin and a pharmaceutical formulation comprising it. The invention further relates to a process for producing said pharmaceutical formulation. Finally, the invention relates to the therape…

USPTO Abstract

The present invention relates to a complex compound comprising obeticholic acid and cyclodextrin and a pharmaceutical formulation comprising it. The invention further relates to a process for producing said pharmaceutical formulation. Finally, the invention relates to the therapeutic use of the complex compound in the treatment of a farnesoid X receptor (FXR) mediated disease or condition.

Drugs covered by this patent

Patent Metadata

Patent number
EP3228306A1
Jurisdiction
EP
Classification
—
Expires
2017-10-11
Drug substance claim
No
Drug product claim
No
Assignee
Ratiopharm GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.